Hepatitis, Chronic clinical trials
The registry lists 837 studies for Hepatitis, Chronic across more than 10 countries. 46 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-24.
Status
- Completed
- 501
- Status unknown
- 188
- Terminated
- 66
- Recruiting
- 32
- Withdrawn
- 21
- Active, not recruiting
- 12
Phase
- Phase 2
- 207
- Phase 3
- 163
- Phase 4
- 161
- Phase 1
- 102
- Early Phase 1
- 4
Where
- China
- 207
- United States
- 164
- Korea, Republic of
- 101
- Taiwan
- 81
- France
- 63
- Canada
- 59
Who runs them
AbbVie (70) · Gilead Sciences (36) · Beijing Ditan Hospital (28) · Merck Sharp & Dohme LLC (25) · Bristol-Myers Squibb (24) · Third Affiliated Hospital, Sun Yat-Sen University (23) · National Taiwan University Hospital (19) · GlaxoSmithKline (18)
Studies
Recruiting first, then most recently updated. Showing 50 of 837 — search for more.
- Evaluation of Patients With Liver DiseaseRecruitingNCT000019711 country
- Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe RegionsRecruitingNCT07654283Phase 26 countries
- Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific RegionRecruitingNCT07370207Phase 27 countries
- Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With CancerRecruitingNCT051818261 country
- A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis BRecruitingNCT07200193Phase 1/24 countries
- Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis BRecruitingNCT06671093Phase 13 countries
- A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)RecruitingNCT06650852Phase 21 country
- A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis BNot yet recruitingNCT069266471 country
- Effects of Peginterferon Consolidation Therapy on Hepatic cccDNA Dynamics in CHB Patients Achieving Clinical Cure.Not yet recruitingNCT06920329Not applicable1 country
- New HBV Infection Biomarkers: Clinical Characterization and Impact on ManagementRecruitingNCT069060161 country
- Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative CHB Patients with Low Level HBsAgNot yet recruitingNCT06900166Phase 41 country
- Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)RecruitingNCT03792919Phase 41 country
- Non-Invasive Model for Fibrosis Regression in HBV PatientsRecruitingNCT068741271 country
- A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis BRecruitingNCT06263959Phase 21 country
- From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B PatientsRecruitingNCT06295328Phase 1/21 country
- Research on Clinical Recovery and Maintenance Strategies for CHBRecruitingNCT06803368Not applicable1 country
- Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in AdultsEnrolling by invitationNCT06777173Not applicable1 country
- An Exploratory Clinical Study Evaluating EPI-003 Injection for the Treatment of Chronic Hepatitis BNot yet recruitingNCT06745973Early Phase 11 country
- A Follow-up Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis BEnrolling by invitationNCT06707922Not applicable1 country
- Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis bRecruitingNCT028836471 country
- Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting InterferonRecruitingNCT066966641 country
- Study of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B PatientsNot yet recruitingNCT06661148Phase 13 countries
- Quantitative CT Imaging Parameters for Assessing Hepatic Steatosis in CHBNot yet recruitingNCT066161031 country
- A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis BRecruitingNCT06566248Phase 21 country
- Find HDV and Determine Its Status in TurkeyRecruitingNCT062485801 country
- Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB PatientsRecruitingNCT06457477Not applicable1 country
- Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）RecruitingNCT06368882Phase 41 country
- Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study）RecruitingNCT06323681Not applicable1 country
- The Effect of Metabolic Syndrome on Antiviral Response in People With Chronic Hepatitis BNot yet recruitingNCT05705141
- Impact of Hepatitis B Virus Genotype on Treatment Response in Children With Chronic Hepatitis BRecruitingNCT062897251 country
- Population-wide Research for HBV-related Liver Diseases in Maoming CityNot yet recruitingNCT06184347
- Characteristics and Risk Factors for Invasive Fungal Infection With Acute-on-chronic Hepatitis B Liver FailureNot yet recruitingNCT06190002
- VACcination of LIver Transplantation CandidatesRecruitingNCT044468321 country
- Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D PatientsRecruitingNCT060510451 country
- A Non-invasive Model to Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis BNot yet recruitingNCT06041022
- Dynamic Changes of Serum HBV RNA in Chronic Hepatitis B PatientsNot yet recruitingNCT059915311 country
- Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention.Enrolling by invitationNCT05956379Not applicable1 country
- Clinical Study to Evaluate the Safety, Tolerance and Pharmacokinetic Characteristics of Single Administration of HRS-5635 Injection in Chinese Healthy Subjects and the Safety, Tolerance, Pharmacokinetics and Antiviral Effect of Multiple Administration in Patients With Chronic Hepatitis BRecruitingNCT05808374Phase 11 country
- A Study to Assess the Efficacy and Safety of Burfiralimab(hzVSF-v13) and OAD (Oral Antiviral Drug)RecruitingNCT05808335Phase 21 country
- Clinical Efficacy and Safety of Tenofovir Disoproxil Fumarate and Entcavir in Treatment of Chronic Hepatitis B Patients in Upper EgyptRecruitingNCT058744401 country
- Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLDRecruitingNCT057664491 country
- Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate PhaseRecruitingNCT056617861 country
- Peginterferon Treatment Study for Inactive Chronic Hepatitis B PatientsRecruitingNCT05182463Phase 41 country
- The Effectiveness and Safety of Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Patients With Mildly Elevated Alanine Aminotransferase and Significant Liver Injury.RecruitingNCT04674423Phase 41 country
- The Establishment of Korean Hepatitis B Patients CohortRecruitingNCT041398501 country
- Real World Study of Chronic Viral HepatitisRecruitingNCT040259441 country
- DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus InfectionActive, not recruitingNCT02772003Phase 12 countries
- Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1)CompletedNCT05630807Phase 326 countries
- Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)CompletedNCT05630820Phase 327 countries
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB06-036 in Subjects With Chronic Hepatitis BCompletedNCT05828745Phase 12 countries